Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Origin Therapeutics Holdings Inc. C.ORIG

Consumer Cyclical
Origin Therapeutics Holdings Inc is an investment company primarily focusing on investments in the psychedelic industry. The Company plans to invest in opportunities involving, where legally permitted, the research, design, development, testing, production, distribution and sale of psychedelics and services related thereto.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:ORIG)

Fundamentals Snapshot (CSE:ORIG)

Current News (CSE:ORIG)

SAFE SUPPLY AND ORIGIN THERAPEUTICS ANNOUNCES ENGAGEMENT OF RESEARCH CAPITAL AND UPSIZING OF BROKERED FINANCING TO $4 MILLION

GlobeNewswire March 2, 2023

Origin Enters into Binding Letter of Intent with Safe Supply Streaming Co., a Pharmaceutical and Narcotics Investment Company with a First Mover Advantage in the Safe Supply Narcotics Sector

GlobeNewswire January 31, 2023

IIROC Trading Halt - ORIG

Canada NewsWire January 31, 2023

Origin Therapeutics Announces New Director

GlobeNewswire October 31, 2022

Origin Therapeutics' (CSE:ORIG) portfolio company Clairvoyant approved for Phase 2 Psilocybin Therapy Trial

John Ballem  October 19, 2022

Origin Therapeutics' Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland

GlobeNewswire October 18, 2022

Origin Therapeutics Announces Director Resignation

GlobeNewswire October 3, 2022

Origin Therapeutics' (CSE:ORIG) Xpira Pharmaceuticals receive FDA approval for psilocybin

Sabrina Cuthbert September 22, 2022

Origin Therapeutics' Portfolio Company, Xpira Pharmaceuticals, Receives FDA Approval For Psilocybin Trial IND Application

GlobeNewswire September 22, 2022
View More News ››

Opinion & Analysis (CSE:ORIG)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:ORIG)

What just happened?

Hey there, Sooooo something just went down. Can someone explain to me what just happened? thanks!
NoRealPlan - March 6, 2023

RE:$Silo Wellness Now Offers Psilocybin Retreats in Jamaica🍄

HUGE STEAL @ UNDER .05 CENTS. PEOPLE ARE TALKING.
FreeShares - September 12, 2022

$Silo Wellness Now Offers Psilocybin Retreats in Jamaica🍄

Go Natural Jamaica, is operated by publicly traded psychedelics company Silo Wellness and located in Long Bay, Portland, Jamaica. “We...
2023me - September 10, 2022
View more Bullboard ››

Jourdan Resources Inc.

Jourdan Resources Inc.

Jourdan Resources Inc is an exploration-stage mining company. It is engaged in the acquisition, exploration and development ...
View More »